Bank of New York Mellon’s Cano Health, Inc. CANO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-8,167
Closed -$207K 4441
2023
Q3
$207K Buy
8,167
+307
+4% +$25.2K ﹤0.01% 3950
2023
Q2
$1.09M Buy
7,860
+2,401
+44% +$308K ﹤0.01% 3147
2023
Q1
$497K Sell
5,459
-69
-1% -$9.37K ﹤0.01% 3493
2022
Q4
$757K Sell
5,528
-65
-1% -$22K ﹤0.01% 3333
2022
Q3
$4.85M Buy
5,593
+226
+4% +$142K ﹤0.01% 2309
2022
Q2
$2.35M Buy
5,367
+4,585
+586% +$2.39M ﹤0.01% 2742
2022
Q1
$497K Buy
782
+125
+19% +$78.8K ﹤0.01% 3714
2021
Q4
$585K Hold
657
﹤0.01% 3700
2021
Q3
$833K Buy
+657
New +$796K ﹤0.01% 3502

Other funds holding CANO

Bank of New York Mellon's CANO Position: Q4 2023 in Review

Bank of New York Mellon sold out of Cano Health, Inc. (CANO) in Q4 2023, closing a stake of 8,167 shares — an estimated $207K sold.

Bank of New York Mellon first reported a position in CANO in Q3 2021 and held it in 9 quarters. The position peaked at $4.85M in Q3 2022. 50 funds tracked by Wall St. Rank hold CANO as of Q4 2023.

  • Bank of New York Mellon reported no remaining Cano Health, Inc. position as of Q4 2023 after selling out during the quarter.
  • Bank of New York Mellon sold 8,167 Cano Health, Inc. shares in Q4 2023, an estimated $207K.
  • Bank of New York Mellon first reported a position in Cano Health, Inc. in Q3 2021 and held it in 9 quarters.
  • Bank of New York Mellon's Cano Health, Inc. position peaked at $4.85M in Q3 2022.
  • 50 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2023.

Based on Bank of New York Mellon's 13F filing for Q4 2023, filed 29 Jan 2024.